Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 81,385 shares at $57.05 ($4.6M) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Scheduled sale ($4.6M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.72 | 907 | $51K | 1.1% |
| 2 | $56.78 | 5,750 | $326K | 7.1% |
| 3 | $56.78 | 4,900 | $278K | 6.0% |
| 4 | $56.79 | 4,115 | $234K | 5.1% |
| 5 | $56.79 | 200 | $11K | 0.2% |
| 6 | $56.79 | 700 |
| $40K |
| 0.9% |
| 7 | $56.80 | 15,135 | $860K | 18.6% |
| 8 | $56.80 | 12,318 | $700K | 15.1% |
| 9 | $56.81 | 2,300 | $131K | 2.8% |
| 10 | $56.81 | 2,800 | $159K | 3.4% |
| 11 | $56.82 | 4,403 | $250K | 5.4% |
| 12 | $56.83 | 3,697 | $210K | 4.5% |
| 13 | $56.83 | 200 | $11K | 0.2% |
| 14 | $56.84 | 2,200 | $125K | 2.7% |
| 15 | $56.85 | 100 | $6K | 0.1% |
| 16 | $56.85 | 1,560 | $89K | 1.9% |
| 17 | $56.86 | 100 | $6K | 0.1% |
| 18 | $56.87 | 4,300 | $245K | 5.3% |
| 19 | $56.87 | 700 | $40K | 0.9% |
| 20 | $57.05 | 100 | $6K | 0.1% |
| 21 | $57.05 | 7,000 | $399K | 8.6% |
| 22 | $57.05 | 4,163 | $237K | 5.1% |
| 23 | $57.06 | 3,737 | $213K | 4.6% |
| Total | $56.85 avg | 81,385 | $4.6M | 100% |
| Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |
| ABT | SELL | 2011-02-10 | $2.4M | — | Filing → |